1. Introduction
===============

Snake envenomation is an important health problem and occupational hazard among outdoor workers, such as farmers, plantation workers and agricultural harvesters, in tropical and subtropical areas, where venomous snakes have a habitat predilection \[[@B1-toxins-06-01526],[@B2-toxins-06-01526],[@B3-toxins-06-01526]\]. It has been estimated that more than 50,000 deaths occur yearly from the snakebites \[[@B3-toxins-06-01526]\]. The majority of cases were from rural areas where access to healthcare facilities is limited and antivenins are usually not available \[[@B1-toxins-06-01526],[@B2-toxins-06-01526],[@B3-toxins-06-01526],[@B4-toxins-06-01526],[@B5-toxins-06-01526]\]. The treatment mainstay of the venomous snakebites in Thailand relies on the horse-derived antivenins produced by Queen Saovabah Memorial Institute (QSMI), Bangkok. The antivenins may be either monospecific for cases when the causative snakes are known or polyspecific, which neutralizes more than one venom species when biting snakes are not identified \[[@B5-toxins-06-01526]\]. The therapeutic efficacy of the latter depends highly on the amounts of the antibodies that could neutralize the heterologous causative venom components (paraspecificity) \[[@B6-toxins-06-01526],[@B7-toxins-06-01526]\]. Therefore, insight into the venom proteomes of individual venomous snake species that inhabit common geographical areas/localities, like *O. hannah* and *N. kaouthia*, which produce similar clinical features \[[@B7-toxins-06-01526],[@B8-toxins-06-01526]\] and the identification of common components shared among their venoms should be useful information for treatment indication when homologous and polyspecific antivenins are not available. In this study, the *O. hannah* venom proteome was characterized, and the components cross-reactive to horse derived-monospecific *N. kaouthia* antivenin were determined. Paraspecific immunity mediated by the antivenin was evaluated also in mice.

Basically, treatment with the horse-derived antivenins is highly effective. Nevertheless, there have been limitations in the production, supply and use of the remedies. The production of immune sera in large animals requires adequate and appropriate animal husbandry, including pasture for grazing, shelter, an animal care taker and a veterinarian. For immunization, the snake venom or a mixture of venoms of several snake species in the immunological adjuvant is injected into the animal at multiple sites. Several boosters are required over an extended period of time (6--12 months or longer) in order to expect the satisfactory serum antibody levels. The quality of the antivenin is subjected to batch-to-batch/animal-to-animal variation. The amount of immune globulin obtained from individual animals at each bleeding time is limited. As such, in some regions of the world where antivenin is not available, many snake bitten subjects receive only traditional panaceas and/or palliative treatment. Besides, the preparations also contain a large fraction of nonspecific proteins. Thus, the antivenin dosage for the treatment of snakebites has never been certain and can be based only on the degree of envenomation \[[@B9-toxins-06-01526]\]. Approximately 20% of the recipients develop either immediate hypersensitivity, including allergy and anaphylaxis and/or late serum sickness, due to the human anti-animal isotype response \[[@B6-toxins-06-01526]\]. Although the early adverse reactions are readily managed in clinical settings with the use of adrenaline, anti-histamines and steroids, the late anti-animal isotype response is difficult to avoid. With contemporary technology, such as the phage display technique, the production of standardized recombinant antibodies to any required target antigen is possible *in vitro* without the prolonged animal immunization process and *in vivo* immune regulations by using the antibody phage display library as a biological tool \[[@B10-toxins-06-01526]\].

Recently, human single-chain variable antibody fragments (HuScFv) specific to *N. kaouthia* long neurotoxin (NkLN-HuScFv) were produced *in vitro* \[[@B10-toxins-06-01526]\]. The engineered HuScFv could rescue the *N. kaouthia* envenomized mice from lethality. Moreover, humanized-camel single-domain antibodies (sdAb) specific to *N. kaouthia* phospholipase A2 (PLA~2~) prepared from a humanized-camel VH/V~H~H (nanobody) phage display library have been shown to neutralize the enzymatic activity of the detrimental enzyme \[[@B11-toxins-06-01526]\]. Therefore, it is envisioned that a cocktail of human/humanized-small antibodies, which are devoid of Fc fragments (thus, not causing an additional inflammatory response) and specific to venomous components should be a possible future road for anti-snake venom design. In this study, the ability of NkLN-HuScFv in rescuing the *O. hannah* envenomed mice from lethality was determined as an example of recombinant-specific antibodies that can mediate paraspecificity.

2. Materials and Methods
========================

2.1. Animals
------------

Male Institute of Cancer Research (ICR) mice, 5 weeks old, were from The National Laboratory Animal Center, Mahidol University, Nakhonpathom, Thailand. Animal husbandry and manipulation were performed following the guideline of the National Research Council of Thailand. Animal experiments were approved by the Siriraj Animal Care and Use Committee (SiACUC), Faculty of Medicine, Siriraj Hospital, Mahidol University (COA No. 004/2556).

2.2. O. hannah Venom, Horse-Derived N. kaouthia Antivenin and HuScFv-Specific to N. kaouthia Long Neurotoxin (NkLN-HuScFv)
--------------------------------------------------------------------------------------------------------------------------

*O. hannah* holovenom and horse-derived monospecific *N. kaouthia* antivenin (purified equine F(ab)'2) were obtained in lyophilized form from the Queen Saovabah Memorial Institute (QSMI). The lyophilized antivenin was dissolved in ten mL of ultrapure sterile distilled water (UDW), while the venom was dissolved in one mL of normal saline solution (NSS). Protein concentrations of the preparations were determined by using Bradford's reagent (Bio-Rad, Hercules, CA, USA).

For preparing NkLN-HuScFv, the gene sequence coding for the HuScFv (*huscfv*) in phagemid transformed *E. coli* clone no. P8/22/3 \[[@B10-toxins-06-01526]\] was subcloned into pET23b^+^, and the recombinant plasmids were put into BL21 (DE3) *E. coli*. The transformed bacteria were grown under IPTG induction condition, and soluble NkLN-HuScFv was purified from the bacterial lysate by using Ni-NTA affinity resin (Thermoscience, Rockford, IL, USA). The *E. coli-*derived NkLN-HuScFv has been shown to neutralize *N. kaouthia* neurotoxin and rescued the *N. kaouthia* envenomed mice from lethality \[[@B10-toxins-06-01526]\]. By using the phage peptide mimotope search and multiple alignments, the HuScFv was found to bind to amino acids in loop 3 of *N. kaouthia* long neurotoxin (accession No. 229777), which is the venom binding site to the neuronal acetylcholine receptor (AchR) \[[@B10-toxins-06-01526]\].

2.3. Characterization *of* O. hannah Venom Proteome by 1DE-ESI-LC-MS/MS
-----------------------------------------------------------------------

*O. hannah* venom was denatured by heating at 95 °C for 5 min in sample buffer (60 mM Tris-HCl, pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, 1% (v/v) β-mercaptoethanol and bromophenol blue). The sample was subjected to 12% SDS-PAGE and stained with Coomassie Brilliant Blue R-250 (CBB) dye. The SDS-PAGE gel was cut horizontally into 10 equal pieces, destained in 100 μL of 50% (v/v) acetonitrile in ammonium bicarbonate and 100 µL of 4 mM dithiothreitol (DTT), kept at 60 °C for 15 min, alkylated by adding 7 µL of 250 mM iodoacetamide and kept in the dark for 40 min. Excess iodoacetamide was quenched with 3 µL of 4 mM dithiothreitol (DTT). All preparations were dehydrated by using acetonitrile, rehydrated with trypsin solution and incubated at 37 °C overnight. Peptides were extracted from each gel by adding acetonitrile; the supernatant was collected, and the acetonitrile was removed by using speed-vac (Eppendorf, Hamburg, Germany). The samples were subjected to mass spectrometric analysis using ESI-LC-MS/MS (a micrOTOF-Q instrument, Bruker Daltonics, Bremen, Germany). Each peptide preparation was acidified before injecting into an EASY-nLC system (Bruker Daltonics), and the separation was done at a flow rate 300 nL/min. The eluent was sprayed using a capillary voltage of 22 to 28 kV into a nano-electrospray source of the QToF. The cone was at 100 V; the source temperature was 85 °C, and the microchannel plate detector (MCP) was 2300 V. The MS scan mode covered *m/z* 400--2000. Three most abundant precursors were selected to fragment for 3 s. The MS/MS spectra covered *m/z* 50--1500. For data analysis, the LC-MS/MS data files were searched against Mascot version 2.4.1 (Matrix Science, London, UK) \[[@B12-toxins-06-01526]\], which contained 37,848,116 sequence entries, respectively, was used. Bony vertebrate was set for the taxonomy filter. Missed cleavage was set to 1 with peptide tolerance set to 200 ppm and tandem MS tolerance set to 0.6 Da. Fixed modification was set to carbamidomethyl on cysteine. Variable modifications were set to include methionine oxidation. Only peptides identified above 95% confidence were reported in this study. Each identified peptide was searched against Basic Local Alignment Search Tool (BLAST) \[[@B13-toxins-06-01526]\] for considering isoforms of proteins \[[@B14-toxins-06-01526]\].

2.4. Determination of O. hannah Venom Components Cross-Reactive with N. kaouthia Antivenin
------------------------------------------------------------------------------------------

*O. hannah* venom was subjected to two-dimensional gel electrophoresis (2DE) \[[@B15-toxins-06-01526]\]. Three aliquots of 75 µg of the *O. hannah* venom were each dissolved in a DeStreak^TM^ rehydration solution that contained pH 3--10 NL IPG buffer (the final volume was 125 µL), and each solution was added into a strip holder of the Ettan IPG Phor Electrofocusing System (Amersham Biosciences). An IPG strip was placed into each strip holder containing the venom (right side down) and allowed to rehydrate at 20 °C for 12 h. Electrophoresis of the IPG strips was performed at 300 V for 30 min, 1000 V for 30 min and 5000 V for 72 min. For the second dimension, the focused IPG strips were equilibrated in a reduction buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, 0.002% bromophenol blue and 1% (w/v) DTT\] at 25 °C for 15 min and in an alkylation buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, 0.002% bromophenol blue and 2.5% (w/v) iodoacetamide) at 25 °C for 15 min. The SDS-PAGE was carried out in a 15% gel cast in Mini PROTEAN^®^ 3 Cell (Bio-Rad) at 10 mAmp/gel during the first 15 min and 20 mAmp/gel until the tracking dye reached the lower gel edge. One gel was stained by CBB dye; the separated components of the other two gels were transferred to two nitrocellulose membranes (NC) for 2DE-immunoblotting. One NC blot was probed with horse monospecific *N. kaouthia* antivenin (1:100), while another blot was probed with normal horse immunoglobulin (equal protein concentration to 1:100 of antivenin). The *O. hannah* components bound by the horse antibodies were revealed by using goat anti-horse immunoglobulin-alkaline phosphatase (AP) conjugate (Southern Biotech, Birmingham, AL, USA) and 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT) substrate (KPL, Gaithersburg, MD, USA). The venom spots on the CBB stained 2DE-gel relevant to the spots that reacted to the horse antivenin on the first 2DE immunoblot membrane, but that did not react to the normal horse immunoglobulin on the second immunoblot membrane were excised out and digested with trypsin. Peptides were subjected to protein identification by ESI-LC-MS/MS using a micrOTOF-Q instrument (Bruker Daltonics, Bremen, German). Each identified peptide was searched against the *O. hannah* nucleotide database.

2.5. Median Lethal Dose (LD~50~) of O. hannah Venom in Mice
-----------------------------------------------------------

The LD~50~ of *O. hannah* venom in mice was determined using a previously established method \[[@B16-toxins-06-01526],[@B17-toxins-06-01526],[@B18-toxins-06-01526]\]. Mice (6 mice per group) were injected with varying amounts of *O. hannah* venom in 200 µL of sterile NSS intraperitoneally (i.p.). Alternatively, mice were injected intramuscularly (i.m.) with *O. hannah* venom in 30 µL of sterile NSS in order to simulate the most common route of the snakebites. Control mice received NSS only. The mortality of the mice in all groups was observed, and the experiments were terminated at 48 h post-injection. The LD~50~ of the i.p. and the i.m. injected venom were calculated from two reproducible experiments \[[@B19-toxins-06-01526]\].

2.6. Cross-Neutralization of O. hannah Venom by N. kaouthia Antivenin
---------------------------------------------------------------------

The cross-species neutralization of the *N. kaouthia* antivenin was performed as described previously \[[@B17-toxins-06-01526],[@B18-toxins-06-01526]\]. Seven groups of 5 mice each (Groups 1--7) were prepared. *O. hannah* venom (1.5 LD~50~) was mixed with the *N. kaouthia* antivenin in 1:5, 1:10, 1:20 or 1:40 (w/w) and kept at 37 °C for 30 min. Individual mice of Groups 1--4 (test groups) were injected i.p. with the venom-antivenin mixtures (500 μL) \[[@B16-toxins-06-01526],[@B17-toxins-06-01526],[@B18-toxins-06-01526]\]. Each mouse of Group 5 received normal horse serum (an equal protein concentration to Group 4) in 500 μL NSS (background neutralization control). Mice of Group 6 received 1.5 LD~50~ *O. hannah* venom in 500 μL NSS (non-neutralization control). Mice of Group 7 received *N. kaouthia* antivenin only (an equal protein concentration to Group 4 in 500 μL NSS) and served as non-envenomed control. The numbers of dead and alive mice at 48 h post-injection were recorded, and the antivenin effective dose (ED~50~) was calculated \[[@B19-toxins-06-01526]\].

Alternatively, six groups of 5 mice each (Groups 1--6) were injected i.m. individually with 1.5 LD~50~ of *O. hannah* venom in 30 µL of NSS (the simulated common route of snakebites). Mice of Group 7 received 30 µL of NSS i.m. Ten minutes later, *N. kaouthia* antivenin (w/w of venom:antibody 1:5, 1:10, 1:20 and 1:40) in 60 µL NSS was injected intravenously (i.v.) (the simulated antivenin treatment route of snakebites in human) into the envenomed mice of Groups 1--4, respectively. Each mouse of Group 5 received normal horse serum (equal protein concentration to the mice of Group 4). Mice of Groups 6 and 7 received 60 µL NSS i.v. alone and the NSS containing *N.* *kaouthia* antivenin (amount of antivenin equal to Group 4), respectively. The numbers of dead and alive mice at 48 h post-venom injection were recorded, and the effective dose (ED~50~) was calculated \[[@B19-toxins-06-01526]\].

2.7. Cross-Neutralization of O. hannah Venom by NkLN-HuScFv
-----------------------------------------------------------

Eight mouse groups (5 mice per group) were prepared (Groups 1--8). *O. hannah* venom (1.5 LD~50~) was mixed with NkLN-HuScFv (1:10 or 1:50 w/w in 500 µL of NSS). *O. hannah* venom (1.5 LD~50~) was also mixed with irrelevant HuScFv (HuScFv specific to the NS1 protein of influenza A virus), at amounts equal to 1:10 or 1:50 venom:HuScFv). The mixtures were kept at 37 °C for 30 min. Individual mice of Groups 1 and 3 (test groups) were injected i.p. with venom-NkLN-HuScFv mixtures at 1:10 and 1:50, respectively; mice of Groups 2 and 4 received *O. hannah* venom mixed with influenza virus NS1-specific HuScFv at 1:10 and 1:50, respectively. Mice of Groups 5 and 6 received *O. hannah* venom in buffer (non-neutralization control) and NkLN-HuScFv alone, respectively. Mice of Groups 7 and 8 received 1.5 LD~50~ of *O. hannah* venom mixed with NkLN-HuScFv and irrelevant HuScFv (venom:antibody 1:50) i.p., respectively; ten minutes later, they were given another i.p. dose of NkLN-HuScFv and the irrelevant HuScFv (an antibody amount equal to Groups 3 and 4, respectively). The numbers of dead and alive mice at 48 h post-injection were recorded and the percent of survival of the mice was calculated.

2.8. O. hannah Venom Components Cross-Reactive to NkLN-HuScFv
-------------------------------------------------------------

*O. hannah* venom was subjected to 2DE, as described above. The separated components were electroblotted onto two pieces of nitrocellulose membranes (NC) The blotted membranes were kept in a Tris-buffered saline solution containing 3% bovine serum albumin (BSA) and 0.2% gelatin (TBST) at 25 °C for 1 h. After blocking, one blotted membrane was probed with the histidine tagged-NkLN-HuScFv and another was reacted with control histidine-tagged HuScFv (specific to influenza virus matrix protein-1) at 25 °C for 1 h and at 4 °C overnight. Separated *O. hannah* components bound by the HuScFvs were revealed by using the mouse anti-histidine tag antibody, goat anti-mouse immunoglobulin-AP conjugate and BCIP/NBT substrate, respectively. The venom protein spots on the 2DE-gel stained with CBB dye relevant to the spots that appeared on the 2DE-immunoblot membrane probed with NkLN-HuScFv, but that were absent on the membrane probed with the irrelevant HuScFv were excised out and digested with trypsin. Peptides were subjected to protein identification by ESI mass spectrometry using the Ultimate 3000 nano HPLC system (Dionex) coupled to a 4000 Q TRAP mass spectrometer (Applied Biosystems). Tryptic peptides were loaded onto a C18 PepMap100, 3 µm (LC Packings) and separated with a linear gradient of water/acetonitrile/0.1% formic acid (v/v). Spectra were analyzed to identify the proteins of interest using Mascot sequence matching software (Matrix Science) with the Ludwig non-redundant (NR) database.

2.9. Computerized Procedure for Determining the Interactions between NkLN-HuScFv and Long Neurotoxins of N. kaouthia and O. hannah
----------------------------------------------------------------------------------------------------------------------------------

Interactions between NkLN-HuScFv with *N. kaouthia* and *O. hannah* long neurotoxins were elucidated by using computerized simulation. The amino acid sequences of the venom proteins were obtained from the UniProt Protein Knowledgebase \[[@B20-toxins-06-01526]\]. The venom protein sequences were used for searching experimental three-dimensional (3D) structures of the venom components by means of the Protein Model Portal \[[@B21-toxins-06-01526]\] from the Research Collaboratory for Structural Bioinformatics (RCSB) protein data bank \[[@B22-toxins-06-01526]\]. Only the 3D structure of *N. kaouthia* long neurotoxin was available. Thus, the amino acid sequence of the *O. hannah* long neurotoxin, as well as the NkLN-HuScFv sequence were subjected to homology modeling \[[@B23-toxins-06-01526],[@B24-toxins-06-01526]\] by the Iterative Threading Assemble Refinement (I-TASSER) server service \[[@B25-toxins-06-01526]\]. The predicted models derived from I-TASSER were subsequently refined by using two server services, *i.e.*, the high-resolution protein structure refinement, ModRefiner \[[@B26-toxins-06-01526],[@B27-toxins-06-01526]\], and the fragment-guided molecular dynamics (FG-MD) simulation \[[@B28-toxins-06-01526],[@B29-toxins-06-01526]\]. The local geometric and physical qualities of the predicted 3D structures were improved to make them come closer to their native state. The refined models were docked according to a fast Fourier transform (FFT)-based program, *i.e.*, PIPER. The antibody-venom component dockings were performed by using the antibody mode available on the automated ClusPro 2.0 protein-protein docking server \[[@B30-toxins-06-01526],[@B31-toxins-06-01526],[@B32-toxins-06-01526],[@B33-toxins-06-01526],[@B34-toxins-06-01526]\]. The largest cluster size, which indicated a region of local minimum energy and a near-native state protein conformation, was chosen for each docking. The protein structure models and the molecular interactions were built and visualized by using PyMOL software (The PyMOL Molecular Graphics System, Version 1.3r1 edu, Schrodinger, LLC, NY, USA).

3. Results
==========

3.1. O. hannah Venom Proteome
-----------------------------

The proteins of the *O. hannah* venom ranged in masses from \<10 to 130 kDa ([Figure 1](#toxins-06-01526-f001){ref-type="fig"}). The trypsin digested peptides of proteins in each gel piece of the [Figure 1](#toxins-06-01526-f001){ref-type="fig"} were subjected to ESI-LC-MS/MS analysis and database search. The *O. hannah* venom peptides matched with the peptides of the proteins of the database are shown in [Table 1](#toxins-06-01526-t001){ref-type="table"}. They could be classified into 14 different protein types/families ([Table A1](#toxins-06-01526-t005){ref-type="table"}), *i.e.*, three finger toxin, phospholipase, cysteine-rich secretory protein (CRiSP), cobra venom factor/complement C3, muscarinic toxin, L-amino acid oxidase, hypothetical protein, low cysteine protein, phosphodiesterase, protease, Vespryn toxin, Kunitz, growth factor activator and others (coagulation factor, endonuclease, 5'-nucleotidase).

![SDS-PAGE separated pattern of *O. hannah* holovenom. M, protein molecular weight standard. Lane 1, SDS-PAGE separated components of the venom stained with Coomassie Brilliant Blue R-250 (CBB) dye. Numbers on the right are the gel pieces containing the *O. hannah* proteins that were subjected to protein identification by LC-MS/MS. Numbers at the left are protein molecular masses (kDa).](toxins-06-01526-g001){#toxins-06-01526-f001}

3.2. O. hannah Venom Components Cross-Reactive to N. kaouthia Antivenin
-----------------------------------------------------------------------

The majority of the venom proteins after 2DE and CBB staining were located in two areas: the \~10--17 and \~26--130 kDa regions ([Figure 2](#toxins-06-01526-f002){ref-type="fig"}). Ten protein spots reacted to the *N. kaouthia* antivenin, but did not react to the normal horse immunoglobulin ([Figure 3](#toxins-06-01526-f003){ref-type="fig"}). The *O. hannah* venom peptides generated from the protein spots that matched with the protein sequences of the database are shown in [Table 2](#toxins-06-01526-t002){ref-type="table"}. They could be classified into six functionally different proteins ([Table A2](#toxins-06-01526-t006){ref-type="table"}) including: cobra venom factor/complement C3, *i.e.*, *O. hannah* venom factor precursor protein (Spots 1 and 3); cardiotoxin-like protein (three finger toxin) (Spot 2); cysteine-rich secretory protein (CRiSP), ophanin/opharin/opharin precursor (Spots 5 and 6); weak neurotoxin precursor (three finger toxin) (Spots 7 and 10); long chain neurotoxin (three finger toxin) (Spots 8--10); short chain α-neurotoxin (three finger toxin) (Spots 9 and 10). No protein in the database matched the peptides of spot 4.

toxins-06-01526-t001_Table 1

###### 

LC-MS/MS Mascot results of in-gel tryptic digestions of *O. hannah* venom searching against the NCBInr database.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gel piece No.   Protein No.   Accession No.   Protein                                                           Protein score   Mass      *m/z*      z   Peptide score   Sequence
  --------------- ------------- --------------- ----------------------------------------------------------------- --------------- --------- ---------- --- --------------- ---------------------------
  1               1             gi\|391359389   Zinc                                                              911             69,003    650.38     2   43.19           NNLLHFSIWR

                                                metalloproteinase-                                                                          799.97     2   64.70           TNNVIIPCKPTDVK

                                                disintegrin-like                                                                            821.39     2   102.49          LYCTGGTENPSEGEK

                                                ohanin                                                                                      861.43     2   96.53           ASYSEIEDIGMVDHR

                                                                                                                                            957.01     2   136.20          AMCDVLQSVGIVQDYSK

                                                                                                                                            1,214.54   2   126.32          NECDLPEFCIGQSAECPMDR

                                                                                                                                            810.39     3   78.10           LYCTGGTENPSEGEKISSDPCK

                                                                                                                                            1,220.67   2   122.89          NDNAQLLTGVDLNGYTLGSAYLK

                                                                                                                                            1,222.53   2   83.89           NECDLPEFCIGQSAECPMDR

                                                                                                                                            860.11     3   74.59           SPYLVGAAMAHEIGHNLGMEHDTK

                                                                                                                                            947.44     3   65.64           NECDLPEFCIGQSAECPMDRFHK

  1               2             gi\|347595788   L-amino-acid oxidase                                              537             55,941    690.87     2   62.68           QTDENAWYLIK

                                                                                                                                            749.50     2   69.76           KIVIVGAGISGLTAAK

                                                                                                                                            762.92     2   66.38           EAGHEVVILEASDR

                                                                                                                                            776.45     2   64.94           IILVCTDKFWEK

                                                                                                                                            1,056.01   2   117.64          MSANNPENFGYQLNPNER

                                                                                                                                            780.07     3   63.43           IYFAGEYTAHPHGWIETSMK

                                                                                                                                            805.42     3   91.79           SASQLFDETLDKVTDDCTLQK

  1               3             gi\|22654267    Acidic phospholipase                                              510             16,432    792.41     2   101.70          LPACSSIMDSPYVK

                                                A2                                                                                          906.40     2   86.21           CCQVHDNCYTQAQK

                                                                                                                                            915.89     2   94.20           ADNDECAAFICNCDR

                                                                                                                                            794.71     3   129.81          YADYGCYCGAGGSGTPVDKLDR

                                                                                                                                            872.10     3   97.84           VAAHCFAASPYNNNNYNIDTTTR

  1               4             gi\|126035663   Complement-                                                       235             184,237   955.61     2   124.43          LILNTPLDTQSLLITVR

                                                depleting factor                                                                            999.02     2   68.09           TDTEEQILVEAHGDNTPK

                                                (*O. hannah*)                                                                               1,065.65   2   42.31           AVPFVIVPLQQGLHDIEVR

  1               5             gi\|82193162    Long neurotoxin OH-37                                             183             9846      670.36     2   91.89           KLSFGCAATCPK

                                                                                                                                            1,164.04   2   91.17           VNPGIDIECCSTDNCNPHPK

  1               6             gi\|338855302   Phosphodiesterase 1                                               160             96,311    771.08     3   95.44           NPAWWGGQPIWHTATYQGLK

                                                                                                                                            1,216.13   2   65.03           NEVTSFENIEVYNLMCDLLK

  1               7             gi\|82193155    Short neurotoxin OH-35                                            126             9558      1,239.13   2   126.42          QYTIFGVTPEICADGQNLCYK

  1               8             gi\|565306229   Insulin-like growth factor I (*O. hannah*)                        115             12,329    936.45     2   115.04          GIVEECCFQSCDLVR

  1               9             gi\|565293365   Hypothetical protein L345_17517, partial (*O. hannah*)            65              25,866    777.87     2   64.55           GIDSSHWNSYCTK

  1               10            gi\|391359387   Zinc metalloproteinase-disintegrin-like mikarin                   63              18,426    796.44     2   62.61           TNTPEQDRYLQVK

  2               11            gi\|544604740   *Ophiophagus* venom                                               534             183,812   606.86     2   43.11           AVYVLNDKYK

                                                factor                                                                                      8,867.00   2   48.71           YVLPSFEVHLQPSEK

                                                                                                                                            905.04     2   58.82           IKLEGDPGAQVGLVAVDK

                                                                                                                                            955.61     2   118.78          LILNTPLDTQSLLITVR

                                                                                                                                            999.02     2   104.68          TDTEEQILVEAHGDNTPK

                                                                                                                                            1,010.07   2   94.74           YLYGEEVEGVAFVLFGVK

                                                                                                                                            700.05     3   67.01           VPVVSEAIHSEGTTLSDGTAK

                                                                                                                                            810.39     3   43.35           LYCTGGTENPSEGEKISSDPCK

                                                                                                                                            749.51     2   96.89           KVVIIGAGISGLTAAK

  3               12            gi\|565315338   5\~-nucleotidase, partial\                                        53              28,027    958.05     2   53.17           VLLPSFLAAGGDGYYMLK
                                                (*O. hannah*)                                                                                                              

  4               13            gi\|387935404   Alpha- and beta-                                                  510             28,637    573.30     2   95.85           GDSGGPLICNR

                                                fibrinogenase OHS1                                                                          812.40     2   105.35          IIGGFECNEYEHR

                                                                                                                                            818.40     2   77.40           DSCKGDSGGPLICNR

                                                                                                                                            881.50     2   102.54          VMGWGLLTSPEVTFPK

                                                                                                                                            1,325.22   2   128.74          EIQGIVSWGGFPCAQLLEPGVY TK

  4               14            gi\|565314693   Hypothetical protein                                              266             24,222    573.30     2   95.85           GDSGGPLICNR

                                                L345_07470, partial                                                                         818.40     2   77.40           DSCKGDSGGPLICNR

                                                (*O. hannah*)                                                                               1,317.72   2   92.89           QIQGVVSWGGFPCAQLLEPGVYT K

  4               15            gi\|565308117   hypothetical protein                                              206             115,185   650.38     2   49.92           NNLLHFSIWR

                                                L345_12124                                                                                  818.40     2   77.40           DSCKGDSGGPLICNR

                                                (*O. hannah*)                                                                               871.39     2   82.22           NGHSCQNNQGYCFR

                                                                                                                                            957.00     2   74.28           AMCDVLQSVGIVQDYSK

  4               16            gi\|54035743    Cobra venom factor                                                64              184,401   841.91     2   63.74           VYSYYNLDEKCTK

  5               17            gi\|565307033   Hepatocyte growth                                                 174             10,782    981.57     2   104.44          YSNVVQEALIPIIPDYK

                                                factor activator,                                                                           1,161.59   2   69.52           FIQPICLPEASMSFPDYYK

                                                partial (*O. hannah*)                                                                       937.51     2   69.87           GILDENQWESGLFLPR

  5               18            gi\|118151738   Metalloproteinase precursor (*Demansia vestigiata*)               62              68,267    649.30     2   61.92           SAECPTDSFQR

  5               19            gi\|18000318    Cysteine-rich venom protein (*Hydrophis hardwickii*)              58              20,109    888.95     2   57.69           YLYVCQYCPAGNIR

  5               20            gi\|182705250   Zinc metalloproteinase/ disintegrin                               53              71,170    957.00     2   53.19           GMCDPKLSVGLVQDYSK

  6               22            gi\|565292399   Endonuclease domain-                                              234             18,064    848.51     2   75.99           SSTFTLTNIVPQFIK

                                                containing 1 protein                                                                        1,055.56   2   66.13           GCQQTFAVVGAVPGDTYIAR

                                                (*O. hannah*)                                                                               1,162.10   2   94.19           ALQDSQAVLEDYKNLADCNR

                                                                                                                                            888.95     2   74.76           YLYVCQYCPAGNIR

  6               23            gi\|1584763     Phospholipase A2                                                  137             13,447    915.89     2   58.19           ADNDECAAFICNCDR

                                                                                                                                            794.71     3   79.24           YADYGCYCGAGGSGTPVDKLDR

  6               24            gi\|565304281   Endonuclease domain-containing 1 protein, partial (*O. hannah*)   126             51,035    628.36     2   49.98           FATLYDKQNR

  6               26            gi\|565303552   Phospholipase B-like 1, partial (*O. hannah*)                     71              58,242    869.47     2   73.13           DLHYATVYWLEAEK

  7               27            gi\|225547744   Opharin precursor                                                 317             26,288    640.78     2   43.67           CPASCFCHNK

                                                (*O. hannah*)                                                                               788.39     2   78.40           YKDDFSNCQSLAK

                                                                                                                                            888.95     2   77.95           YLYVCQYCPAGNIR

                                                                                                                                            1,092.02   2   68.72           FSCGENLFMSSQPYAWSR

                                                                                                                                            1,212.51   2   48.66           SGPPCGDCPSACDNGLCTNPCK

  8               29            gi\|124020977   PLA~2~ Hs-1 precursor (*Hoplocephalus stephensii*)                61                        915.88     2   60.84           ADNDECKAFICNCDR

  9               30            gi\|48428841    Cysteine-rich venom protein                                       123             26,229    705.39     2   56.89           VIQSWYDENKK

                                                natrin-2                                                                                    925.46     2   66.57           NMLQMEWNSNAAQNAK

  9               31            gi\|82193154    Cardiotoxin CTX15                                                 104             9,346     545.84     2   60.05           LPSKYDVIR

                                                                                                                                            666.40     2   43.75           CLNTPLPLIYK

                                                                                                                                            738.43     2   42.00           FLEQQNQVLQTK

  9               32            gi\|32363235    Thai cobrin                                                       80              12,087    757.41     3   80.32           ADVTFDSNTAFESLVVSPDKK

  9               33            gi\|26006829    Acidic phospholipase                                              61              15,890    847.13     3   61.15           VAAICFAGAPYNKENINIDTTTR

                                                A2-2                                                                                        792.41     2   105.12          LPACSSIMDSPYVK

                                                                                                                                            906.41     2   77.19           CCQVHDNCYTQAQK

                                                                                                                                            915.89     2   94.44           ADNDECAAFICNCDR

                                                                                                                                            794.71     3   147.85          YADYGCYCGAGGSGTPVDKLDR

                                                                                                                                            1,210.54   2   92.09           TVTCKADNDECAAFICNCDR

                                                                                                                                            872.10     3   101.16          VAAHCFAASPYNNNNYNIDTTTR

                                                                                                                                            925.45     3   109.09          VAAHCFAASPYNNNNYNIDTTTRC

  10              34            gi\|82199673    Cytotoxin-27                                                      251             9,305     799.38     2   67.56           SSADVEVLCCDTNK

                                                (ß Cytotoxin)                                                                               1,102.61   2   115.40          CLNTPLPLIYTTCPIGQDK

                                                                                                                                            1,138.12   2   68.32           KCLNTPLPLIYTTCPIGQDK

  10              35            gi\|82175774    Short neurotoxin                                                  247             8,886     560.25     2   47.13           YSVCCSTDK

                                                OH-46                                                                                       761.34     2   62.70           YSVCCSTDKCNK

                                                                                                                                            929.47     3   137.57          TTMFFPNHPVLLMGCTYNCPTER

  10              36            gi\|123916245   Cardiotoxin CTX21                                                 242             9,249     978.48     2   58.44           SSADVVVVCCDTNKCNK

                                                                                                                                            1,102.61   2   115.4           CLNTPLPLIYTTCPIGQDK

                                                                                                                                            1,138.12   2   68.32           KCLNTPLPLIYTTCPIGQDK

  10              37            gi\|116242842   Ohanin                                                            177             21,161    749.40     2   88.66           FSSSPCVLGSPGFR

                                                                                                                                            1,135.61   2   88.46           ADVTFDSNTAFESLVVSPDKK

                                                                                                                                            1,239.13   2   140.55          QYTIFGVTPEICADGQNLCYK

                                                                                                                                            666.40     2   59.72           CLNTPLPLIYK

                                                                                                                                            799.38     2   67.56           SSADVEVLCCDTNK

                                                                                                                                            1,022.51   2   64.29           VSETIEICPDGQNFCFK

  10              40            gi\|239977312   Protease inhibitor TCI                                            105             8,976     998.00     2   104.67          AYIPSFYYNPDASACQK

  10              41            gi\|123913366   Weak neurotoxin WNTX-34                                           98              9,808     826.35     2   97.90           EIVQCCSTDECNH

  10              42            gi\|82193157    Long neurotoxin OH-17                                             88              8,032     893.90     2   88.18           CCSTDNCNPFTPWK

  10              43            gi\|82193161    Long neurotoxin OH-55                                             82              10,203    1,013.59   2   81.91           VNLGCAATCPIVKPGVEIK

  10              44            gi\|128951      Long neurotoxin-4                                                 75              8,009     941.47     2   75.32           IISEACPPGQDLCYMK

  10              45            gi\|83305935    Neurotoxin-like protein 1                                         74              7,037     625.83     2   74.01           KDEVIQCCAK

  10              46            gi\|182705233   Weak toxin DE-1                                                   74              9,297     650.87     2   73.67           VNPPISIICCK

  10              47            gi\|239938646   Venom chymotrypsin inhibitor                                      52              9,130     830.42     2   52.00           FCELPPEPGLCNAR

  10              48            gi\|123907650   Cardiotoxin CTX-23                                                146             9,290     459.74     2   33.85           TCPIGQDK

                                                                                                                                            666.40     2   58.07           CLNTPLPLIYK

                                                                                                                                            978.48     2   54.36           SSADVVVVCCDTNKCNK

  10              49            gi\|123913365   Muscarinic toxin-38                                               48              9,678     756.38     2   48.13           TCPDGQNLCYKR

  10              50            gi\|128944      Long neurotoxin-2                                                 70                        893.90     2   69.94           CCSTDNCNPFPTWK
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![Pattern of *O. hannah* holovenom proteins after two-dimensional gel electrophoresis (2DE) and CBB staining. Numbers at the left are protein masses in kDa.](toxins-06-01526-g002){#toxins-06-01526-f002}

![Patterns of *O. hannah* venom after 2DE at non-linear pH 3.0--10.0 and probed with (**a**) horse-derived *N. kaouthia* antivenin and (**b**) normal horse serum. Encircled spots and numbers are *O. hannah* proteins that reacted with the antivenin and did not react with the normal horse serum.](toxins-06-01526-g003){#toxins-06-01526-f003}

toxins-06-01526-t002_Table 2

###### 

*O. hannah* venom components cross-reactive with horse-derived *N. kaouthia* antivenin.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gel piece No.   Accession No.                        Protein                                                Protein score   Mass      *m/z*    z   Peptide score   Sequence
  --------------- ------------------------------------ ------------------------------------------------------ --------------- --------- -------- --- --------------- --------------------------
  1               gi\|544604740                        *O. hannah* venom factor                               54              183,812   428.26   2   29.96           VVPEGVQK

                                                                                                                                        710.74   3   26.31           AVPFVIVPLQQGLHDIEVR

  2               gi\|38049474                         Cardiotoxin-like protein                               187             9,818     481.73   2   38.14           GCIDICPK

                                                       (*O. hannah*)                                                          9,818     545.82   3   27.06           LPSKYDVIR

                                                                                                                              9,818     799.36   2   65.14           SSADVEVLCCDTNK

                                                                                                                              9,818     735.39   3   64.75           CLNTPLPLIYTTCPIGQDK

  3               gi\|387165368                        OVF precursor protein\                                 52              185,408   482.26   3   27.04           HFEVGFIQPGSVK
                                                       (*O. hannah*)                                                                                                 

                                                                                                              52              185,408   710.74   3   25.54           AVPFVIVPLQQGLHDIEVR

  4               No matched protein in the database                                                                                                                 

  5               gi\|28972961                         Ophanin (*O. hannah*)                                  82              27,764    567.79   2   29.55           SVSPTASNMLK

                                                                                                                              27,764    640.78   2   54.73           QSSCQDEWIK

  6               gi\|225547744                        Opharin precursor                                      46              27,200    418.73   2   26.72           GSIATPYK

                                                       (*O. hannah*)                                                          27,200    525.91   2   20.06           YKDDFSNCQSLAK

  7               gi\|82570105                         Weak neurotoxin precursor                              53              10,492    484.23   2   28.00           NGENVCFK

                                                       (*O. hannah*)                                                          10,492    551.21   3   25.30           EIVQCCSTDECNH

  8               gi\|82570073                         Long chain neurotoxin precursor (*O. hannah*)          25              11,155    644.28   2   24.64           TWCDVFCGSR

  9               gi\|82570073                         Long chain neurotoxin                                  60              11,155    644.20   2   27.10           TWCDVFCGSR

                                                       precursor (*O. hannah*)                                                          956.40   2   32.50           IISETCPPGQDLCYMK

                  gi\|51105381                         Long chain neurotoxin                                  123             8,602     603.20   2   49.40           IDLGCAATCPK

                                                       precursor (*O. hannah*)                                                          659.20   2   50.12           SWCDVFCTSR

                                                                                                                                        837.30   2   23.54           SETCPDGENICYTK

                  gi\|51105369                         Long chain neurotoxin                                  60              10,477    606.20   2   27.95           LSFGCAATCPK

                                                       precursor (*O. hannah*)                                                          642.70   2   32.33           SWCDAWCGSR

  9               gi\|51105375                         Long chain neurotoxin                                  38              10,538    595.70   2   37.91           VNLGCAATCPK

                                                       precursor (*O. hannah*)                                                                                       

                  gi\|82570079                         Long chain neurotoxin                                  74              10,944    491.20   2   41.32           CYVTPDVK

                                                       precursor (*O. hannah*)                                                          837.30   2   32.65           SETCPDGENICYTK

                  gi\|128944                           Long neurotoxin-2                                      72              8,602     603.20   2   43.12           IDLGCAATCPK

                                                       (Neurotoxin B)                                                                   937.00   3   28.64           TKCYVTPDATSQTCPDGQDICYTK

                  gi\|51105373                         Long chain neurotoxin                                  77              10,830    491.20   2   31.89           CYVTPDVK

                                                       precursor (*O. hannah*)                                                          676.00   3   45.21           VNLGCAATCPIVKPGVEIK

                  gi\|51105391                         Short chain alpha neurotoxin precursor (*O. hannah*)   36              10,071    826.30   3   35.67           QYTIFGVTPEICADGQNLCYK

  10              gi\|51105397                         Short chain alpha                                      114             9,859     481.70   2   29.87           GCIDICPK

                                                       neurotoxin precursor                                                             666.30   2   36.34           CLNTPLPLIYK

                                                       (*O. hannah*)                                                                    667.20   3   47.91           SSADVEVLCCDTNKCNK

                  gi\|82570105                         Weak neurotoxin                                        46              10,492    826.20   2   46.23           EIVQCCSTDECNH

                                                       precursor (*O. hannah*)                                                          799.30   2   41.31           SSADVEVLCCDTNK

                                                                                                                                        667.20   3   27.16           SSADVEVLCCDTNKCNK

                  gi\|82570079                         Long chain neurotoxin                                  146             10,944    491.20   2   38.11           CYVTPDVK

                                                       precursor (*O. hannah*)                                                          837.30   2   36.70           SETCPDGENICYTK

                                                                                                                                        596.20   3   27.89           CCSTDNCNPFTPWK

                                                                                                                                        648.20   3   43.67           CCSTDNCNPFTPWKR

                  gi\|128944                           Long neurotoxin 2                                      167             8,602     603.20   2   27.85           IDLGCAATCPK

                                                       (Neurotoxin B)                                                                   596.20   3   33.17           CCSTDNCNPFPTWK
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

toxins-06-01526-t003_Table 3

###### 

Efficacy of HuScFv specific to *N. kaouthia* long neurotoxin (NkLN-HuScFv) in the cross-neutralization of *O. hannah* venom.

  Group of mice   Treatment (injected i.p. with)                                                           Ratio of venom : HuScFv (w/w)   Mean ± SD of mouse dead time ( min)           \% Survival
  --------------- ---------------------------------------------------------------------------------------- ------------------------------- --------------------------------------------- -------------
  1               Venom-NkLN-HuScFv mixture                                                                1:10                            111 ± 16.5 ^a^                                0
  2               Venom-irrelevant HuScFv mixture                                                          1:10                            88 ± 7.2 ^b^                                  0
  3               Venom-NkLN-HuScFv mixture                                                                1:50                            155 ± 58.7 ^a^                                0
  4               Venom-irrelevant HuScFv mixture                                                          1:50                            93 ± 6.8 ^b^                                  0
  5               Venom in buffer                                                                          NA                              78 ± 7.3 ^b^                                  0
  6               NKLN-HuScFv alone                                                                        NA                              All mice survived at the end of experiments   100
  7               Venom-NkLN-HuScFv mixture and followed 10 min later with NkLN-HuScFv alone               1:50                            220 ^a^                                       80
  8               Venom-irrelevant HuScFv mixture and followed 10 min later with irrelevant HuScFv alone   1:50                            95 ± 24.4 ^b^                                 0

Notes: NA, not available. Entries with different superscripts (a *versus* b) were different significantly at *p* \< 0.05 (*t*-test). Irrelevant HuScFv were specific to the influenza A virus M1 protein.

3.3. Median Lethal Dose (LD~50~) of O. hannah Venom and the Venom Cross-Neutralization by the Monospecific N. kaouthia Antivenin
--------------------------------------------------------------------------------------------------------------------------------

The LD~50~ of the *O. hannah* venom injected i.p. and i.m. into mice were 1.1 and 0.59 µg/g of body weight, respectively. All mice that received 1.5 LD~50~ of the *O. hannah* venom either i.p. or i.m. died within 48 h post-injection. Envenomed mice that received only normal horse serum were all dead within 48 h post-injection also, while mice that received *N. kaouthia* antivenin alone survived with no detectable adverse effect. The ED~50~ of the *N. kaouthia* antivenin mixed with 1.5 LD~50~ *O. hannah* venom and injected i.p. to mice was 590 µg per mouse (19.6 µg/g body weight). When used to treat the mice that received 1.5 LD~50~ of *O. hannah* venom i.m., the i.v. antivenin ED~50~ was 404 μg in 60 µL of NSS per mouse or 13.5 μg/g body weight.

3.4. Cross-Neutralization of O. hannah Venom by HuScFv Specific to N. kaouthia Neurotoxin
-----------------------------------------------------------------------------------------

Mice injected with a mixture of *O. hannah* venom (1.5 LD~50~) and NkLN-HuScFv at 1:10 and 1:50 (w/w) (Groups 1 and 2, respectively) had significantly longer death times (111 ± 16.5 and 155 ± 58.7 min, respectively) compared with the mice injected with the venom alone (78 ± 7.3 min) (*p* = 0.00008 and 0.0004, respectively) ([Table 3](#toxins-06-01526-t003){ref-type="table"}). The means ± SD of the death times of NkLN-HuScFv treated mice at the venom:HuScFv ratios of 1:10 and 1:50 were also longer than the irrelevant HuScFv neutralization controls (*p* = 0.01 and 0.04, respectively). Eighty percent of mice that were injected with *O. hannah* venom (1.5 LD~50~) mixed with NkLN-HuScFv (venom:HuScFv ratio 1:50 w/w) i.p. and 10 min later received another therapeutic dose of NkLN-HuScFv survived, while all mice that received 1.5 LD~50~ of the *O. hannah* venom alone or mixed with irrelevant HuScFv i.p. and followed 10 min later by NSS and the irrelevant HuScFv i.p., respectively, died within 48 h post-injection ([Table 3](#toxins-06-01526-t003){ref-type="table"}).

3.5. O. hannah Venom Components Cross-Reactive to NkLN-HuScFv
-------------------------------------------------------------

There were four protein spots (1--4) of the 2DE-*O. hannah* venom that were bound by the NkLN-HuScFv ([Figure 4](#toxins-06-01526-f004){ref-type="fig"}a), but that were not bound by the irrelevant HuScFv ([Figure 4](#toxins-06-01526-f004){ref-type="fig"}b). The proteins in the spots 1 and 2 were identified as three finger toxins, *i.e.*, short and long chain neurotoxins, while no protein in the database matched with the proteins of the spots 3 and 4.

3.6. Computerized Models of Interactions between N. kaouthia and O. hannah Long Neurotoxins and NkLN-HuScFv
-----------------------------------------------------------------------------------------------------------

The crystal structure of *N. kaouthia* long neurotoxin (CBTX) was found in the database (PDB ID: 1CTX), while the 3D structures of the *O. hannah* long neurotoxin (OH-LNTX28) and NkLN-HuScFv had to be modeled by the I-TASSER service. The modeled scores of the OH-LNTX28 and NkLN-HuScFv were 1.16 and 1.14, while the expected template-modeling (TM) scores were both 0.87 ± 0.07 and the expected similarity (RMSD) scores were 1.2 ± 1.2 and 3.5 ± 2.4 Å, respectively, which indicated the appropriateness of the modeled structures. The details of the interactions between *N. kaouthia* long neurotoxin (CBTX) and *O. hannah* long neurotoxin (OH-LNTX28) with NkLN-HuScFv are shown in [Table 4](#toxins-06-01526-t004){ref-type="table"} and [Figure 5](#toxins-06-01526-f005){ref-type="fig"}. The alignments of the amino acid sequences of *N. kaouthia* and *O. hannah* neurotoxins and the residues of both toxins recognized by NkLN-HuScFv are shown in [Figure 5](#toxins-06-01526-f005){ref-type="fig"}a. The largest clusters obtained from ClusPro 2.0 were 274 and 215 members, respectively. The lowest energies of the representative models of the molecular dockings were −262.9 and −281.2 kcal/mol, respectively. According to the docking outputs, NKLN-HuScFv used the amino acids D55, Y52, Q104, D55/D57, E74 and N28/S31 in the VH domain to interact with six amino acids of the CBTX, including W25, C26, S31 and R36 in loop 2 and K49 and T50 in loop 3 of *N. kaouthia* long neurotoxin, respectively ([Table 4](#toxins-06-01526-t004){ref-type="table"} and [Figure 5](#toxins-06-01526-f005){ref-type="fig"}b,d). The antibody used the VH residues, including Y52, D57, Q104, D57, D54/D55, N28 and S31 of CDRs1-3, to dock on *O. hannah* mature long neurotoxin (Q2VBP4) residues C26, W29, G31, R33 and K36 in loop 2 and R47 and N49 in loop 3 of the *O. hannah* long neurotoxin, respectively ([Table 4](#toxins-06-01526-t004){ref-type="table"} and [Figure 5](#toxins-06-01526-f005){ref-type="fig"}c,e).

![*O. hannah* venom proteins after 2DE and probed with (**a**) NkLN-HuScFv and (**b**) irrelevant HuScFv (control). Encircled spots are the *O. hannah* proteins that reacted with NkLN*-*HuScFv on the 2DE immunoblot membrane, but did not react with the irrelevant HuScFv (specific to the M1 protein of influenza A virus). Proteins in spots 1 and 2 were identified as *O. hannah* three finger toxins, *i.e.*, short and long neurotoxins. No proteins in the database matched with the proteins of spots 3 and 4.](toxins-06-01526-g004){#toxins-06-01526-f004}

toxins-06-01526-t004_Table 4

###### 

Residues of *N. kaouthia* and *O. hannah* long neurotoxins that interacted with NkLN-HuScFv.

  Neurotoxin             NkLN-HuScFv   
  ---------------------- ------------- ----------
  **CBTX (P01391)**                    
  W25                    D55           VH/CDR2
  C26                    Y52           VH/CDR2
  S31                    Q104          VH/CDR3
  R36                    D55, D57      VH /CDR2
  K49                    E74           VH/FR3
  T50                    N28, S31      VH/CDR1
  **OH-LNTX (Q2VBP4)**                 
  C26                    Y52           VH/CDR2
  W29                    D57           VH/CDR2
  G31                    Q104          VH/CDR3
  R33                    D57           VH/CDR2
  K36                    D54, D55      VH/CDR2
  R47                    N28           VH/CDR1
  N49                    S31           VH/CDR1

![(**a**) Alignments of amino acid sequences of *N. kaouthia* and *O. hannah* neurotoxins. The residues in the epitopes recognized by NkLN-HuScFv are contained in the red boxes. (**b**,**c**) Illustrations of the computerized molecular dockings between NkLN-HuScFv (green ribbon) with the long neurotoxins (gray ribbons) of *N. kaouthia* and *O. hannah,* respectively. (**d**,**e**) Space-filling illustrations of the computerized models of the neurotoxins of *N. kaouthia* and *O. hannah,* respectively. NkLN-HuScFv interactive amino acids of the toxins are shown in red ball-like structures. NkLN-HuScFv interacted with amino acids W25, C26, S31 and R36 in loop 2 and K49 and T50 in loop 3 of the *N. kaouthia* long neurotoxin and with the C26, W29, G31, R33 and K36 in loop 2 and R47 and N49 in loop 3 of the *O. hannah* long neurotoxin.](toxins-06-01526-g005){#toxins-06-01526-f005}

4. Discussion
=============

In this study, 1DE gel-based proteomic analysis was used to reveal the *O. hannah* venom proteome. The venom proteins ranged in sizes from \<10 to 170 kDa, which conformed to the previous data \[[@B35-toxins-06-01526]\]. The *O. hannah* venom showed two major protein bands at 10--17 and 72 kDa, which, more or less, similar to the Malaysian *O. hannah* venom that had predominant bands at 15--20 and 100 kDa \[[@B36-toxins-06-01526]\]. The differences observed in different studies should be due to the different geographical areas of the cobras, as well as the technical details \[[@B37-toxins-06-01526]\].

*O. hannah* venom components have been studied previously \[[@B38-toxins-06-01526],[@B39-toxins-06-01526],[@B40-toxins-06-01526]\]. By using 2DE and MALDI-ToF mass spectrometry \[[@B38-toxins-06-01526]\], 12 venom proteins were reported, *i.e.*, weak toxin DE-1, cysteine-rich secretory protein, metallothionein-3, metallothionein, hypothetical proteins, putative DNA invertase, ribosomal protein S17P, small heat stress protein class CIII, XYLDLEGF operon transcriptional activator-II, Phe-Met-Arg-Phe amide neuropeptide precursor, cytochrome c-553 precursor and protein similar to the microtubule-associated RP/EB family. Among these proteins, only the weak toxin, DE-1 and cysteine-rich secretory protein were toxic. Seventeen different protein families in the venom gland of Indonesian king cobra (*Ophiophagus hannah*) were predicted by using a draft genome and deep transcriptome sequencing \[[@B39-toxins-06-01526]\], *i.e.*, three finger toxin, phospholipase-A2 (PLA~2~), acetylcholine esterase, metalloproteinases, cysteine-rich secretory protein, cobra venom factor (CVF), hyaluronidase (HYA), Kunitz (serine protease inhibitor), lectin, nerve growth factor (NGF), natriuretic peptide (NP), peptidase, phospholipase-B (PLB), vascular endothelial growth factor (VEGF), ohanin, waprin (protease inhibitor) and various other proteins. Recently, pooled samples of king cobra venom from Indonesia, Malaysia, Thailand and two provinces of China were found to contain eight novel PLA~2~s. Three finger toxins, *i.e.*, OH-55 (long neurotoxin) and OH-27 (beta cardiotoxin), and the Kunitz inhibitor (OH-TCI) were common in all of the five *O. hannah* venoms. Southeast Asian *O. hannah* venoms contained higher metalloproteinase, acetylcholine esterase and alkaline phosphatase than the Chinese venoms \[[@B41-toxins-06-01526]\]. In this study, *O. hannah* venom proteome were revealed by 1 DE and ESI-LC-MS/MS and found that peptides of the venom matched with 14 different protein types/families of the database. Among them, long and short neurotoxins, weak neurotoxin, muscarinic toxin, phospholipase-A~2~ cardiotoxins, phospholipase-B, zinc metalloproteinases, ohanin, serine protease inhibitor, cobra venom factor (CVF) and cysteine-rich secretory protein (ophanin) proteins were found, which verified the transcriptomic data reported previously \[[@B39-toxins-06-01526]\].

The majority of the venom proteins located at \~10--17 and \~26--130 kDa after 2DE and CBB staining, which reproduced the 1DE data and was relatively similar to the 2DE pattern of *O. hannah* venom reported previously \[[@B36-toxins-06-01526],[@B38-toxins-06-01526]\]. *N. kaouthia* antivenin reacted with ten *O. hannah* proteins, all of which were toxic. *N. kaouthia* and *O. hannah* were both elapid snakes and their venoms shared common components \[[@B38-toxins-06-01526],[@B41-toxins-06-01526]\]. The two snake species also have the same geographical and diet predilection \[[@B42-toxins-06-01526]\]. Therefore, the *in vivo* cross-neutralization of monospecific *N. kaouthia* antivenin against the *O. hannah* venom could be expected.

Cross-neutralization of horse-derived monospecific *N. kaouthia* antivenin of QSMI to *O. hannah* venom was as expected. The effective dose fifty (ED~50~) of the *N. kaouthia* antivenin when mixed with the *O. hannah* venom (1.5 LD~50~) and injected i.p. into the mice was 19.6 µg/g body weight, while the ED~50~ of the antivenin when used to treat the envenomized mice that received the 1.5 LD~50~ of *O. hannah* venom i.m. followed by the antivenin intravenously was 13.5 μg/g body weight. Leong *et al.* \[[@B43-toxins-06-01526]\] reported that the ED~50~ of the QSMI horse-derived *N. kaouthia* antivenom when incubated at 37 °C for 30 min with 2.5 LD~50~ of *O. hannah* venom and injecting the mixtures into the caudal veins of mice was 2.80--3.35 (average 3.07) mg/mL. Because the amount of the antivenin injected into individual mice in the study \[[@B43-toxins-06-01526]\] was not mentioned and also due to the different LD~50~ used, the ED~50~ of the antivenins in the previous and the present studies could not be compared.

The gene sequence coding for HuScFv of clone 8/22/3 \[[@B10-toxins-06-01526]\] that neutralized *N. kaouthia* neurotoxin and that rescued 100% of the *N. kaouthia* envenomized mice from lethality was subcloned from pCANTAB5E phagemid vector into pET23b^+^ plasmid vector in order to improve the HuScFv expression yield. The mice that received intraperitoneally the mixtures of *O. hannah* venom and NkLN-HuScFv at 1:10 and 1:50 showed significantly longer means ± SD of death times than the non-NkLN-HuScFv controls (*p* \< 0.05). Nevertheless, when another therapeutic dose of the NKLN-HuScFv was given to the mice that received the mixture of 1:50 venom:NkLN-HuScFv, 80% of the mice survived at the end of the experiments, indicating that the specific HuScFv could rescue the mice from *O. hannah* envenomation in a dose-dependent manner. By the 2DE immunoblotting, NkLN-HuScFv bound to the short and long chain neurotoxins of the *O. hannah* venom. Thus, the NkLN-HuScFv should mediate the paraspecific protection of the *O. hannah* envenomed mice by neutralizing these lethal venom components.

The 2DE proteomics and the 2DE western blot analysis used for revealing the components of the *O. hannah* venom and the components recognized by the antibody, respectively, have some limitations. The 2DE method may not recognize components present in minute amounts in the holovenom \[[@B41-toxins-06-01526]\]. The 2DE immunoblotting provided a qualitative assessment and did not provide the degree of immunoreactivity (avidity/affinity) of each antigen-antibody interaction. Besides, the antibodies could recognize only the denatured venom components in the assay and, thus, could not reveal the binding of conformational epitopes present in the native proteins.

According to the molecular docking results, NkLN-HuScFv used all three CDRs, as well as FR3 of the VH to dock on six residues of *N. kaouthia* neurotoxin, while the VL domain was refractory. Four neurotoxin residues, *i.e.*, W25, C26, S31 and R 36, are located in the neurotoxin protruded long central loop (loop 2) and the other two, *i.e.*, K49 and T50, are located in loop 3. Both loops are important for high affinity binding of the neurotoxin to the α7 subunit of the neuronal acetylcholine receptor. The results of the 3D structure docking, more or less, conformed to the previous finding, which indicated by means of a phage peptide mimotope search and multiple alignments with the neurotoxin linear sequence that NkLN-HuScFv bound to the 47TVKT50 in loop 3 of the *N. kaouthia* neurotoxin \[[@B10-toxins-06-01526]\]. Multiple alignments of the *N. kaouthia* neurotoxin amino acid sequence with neurotoxin sequences of other snakes indicated that the tentative epitopic peptide of the NkLN-HuScFv existed also in the neurotoxins of heterologous snake species, for example, 47TVKP50 and 47KVKP50 of *O. hannah* neurotoxins (accession No. AAB25587 and P01389, respectively (previous study) and 47RVNP50 (accession No. Q2VBP4 (this study)), 47TVKP50 of *Micrurus nigrocinctus* (accession No. P80548) and *N. melanoleuca* (accession No. P01383 and P01388) and 47KVKP50 of *N. oxiana* (accession No. P01427), *N.* *nivea* (accession No. P01390) and *Dendroaspis polylepis polylepis* (accession No. P01416) \[[@B10-toxins-06-01526]\]. NkLN-HuScFv used all three CDRs of the VH to bind to seven amino acids, *i.e.*, C26, W29, G31, R33 and R36, in loop 2 and R47 and N49 in loop 3 of *O. hannah* long neurotoxin, which are important also for the acetylcholine receptor binding. Taken altogether, the results indicate that NkLN-HuScFv mediated the neurotoxin neutralization by interfering with the toxin binding to the acetylcholine receptors and, consequently, rescuing the envenomed mice from death.

The HuScFv could be prepared *in vitro* without animal immunization, and the molecule is a human protein; thus, it should be appropriate and safe for human use. The small antibodies have high solubility, reproducible refolding capacity and thermal stability, which ease the production process. It is envisaged also that a cocktail of the *in vitro* produced human ScFvs to various toxic venom components shared by different venomous snakes, exemplified by the recombinant NkLN-HuScFv in this study, should contribute to a possible future design of an improved alternative anti-snakebite remedy.

5. Conclusions
==============

By using one-dimensional gel-based proteomics, the *O. hannah* holovenom was found to consist of 14 different protein types/families. *N. kaouthia* antivenin produced by the Queen Saovabah Memorial Institute (QSMI), Bangkok, cross-reacted to several functionally different *O. hannah* venom proteins and could rescue the envenomed mice from lethality. The phage display-derived recombinant *N. kaouthia* long neurotoxin-specific HuScFv cross-neutralized the *O. hannah* short and long neurotoxins and was able to extricate the *O. hannah* envenomed mice from death in a dose escalation manner. The data are useful for snakebite treatment when and where the polyspecific antivenin is not available.
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toxins-06-01526-t005_Table A1

###### 

The orthologous proteins containing peptides matched with *O. hannah* venom peptides.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Protein type/family                           Protein subtype                                   Protein name(s)                                                                                                                                                                                                                                                                                                           Function(s)
  --------------------------------------------- ------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Three-finger toxin                        Long neurotoxin                                   OH-2, OH-4, OH-17, OH-37,OH-55 and LNTX37                                                                                                                                                                                                                                                                                 These three-finger toxins bind to muscular and neuronal nicotinic acetylcholine receptors (α-7-9) and block neuromuscular transmission at the postsynaptic site causing paralysis \[[@B44-toxins-06-01526],[@B45-toxins-06-01526]\].

  Short neurotoxin                              OH-35,                                            This neurotoxin binds to muscarinic acetylcholine receptor and blocks synaptic nerve transmission \[[@B46-toxins-06-01526]\].                                                                                                                                                                                             

                                                OH-46                                             This three-finger toxin binds and inhibits the nicotinic acetylcholine receptor \[[@B47-toxins-06-01526]\].                                                                                                                                                                                                               

  Cardiotoxin/Cytotoxin                         CTX-15 (OH-84), CTX-21 and CTX-23                 These three-finger toxins are cytotoxic and hemolytic \[[@B48-toxins-06-01526]\].                                                                                                                                                                                                                                         

                                                CTX-27 (ß Cardiotoxin)                            Acts as a beta-blocker by binding to beta-1 and beta-2 adrenergic receptors. It dose-dependently decreases the heart rate. At 100 mg/kg, intraperitoneal injection into mice mediate labored breathing, impaired locomotion, lack of response to external stimuli, and death (after 30 min) \[[@B49-toxins-06-01526]\].   

  Weak neurotoxin                               WNTX-34                                           This three-finger toxin binds to muscular and neuronal (α-7) nicotinic acetylcholine receptors with low affinity and very low affinity, respectively \[[@B46-toxins-06-01526]\].                                                                                                                                          

  Neurotoxin-like                               Neurotoxin-like protein 1                         Unknown                                                                                                                                                                                                                                                                                                                   

  Weak toxin                                    OH-DE-1                                           Binds to the muscular nicotinic acetylcholine receptor causes paralysis by blocking neuromuscular transmission at the postsynaptic site \[[@B38-toxins-06-01526],[@B50-toxins-06-01526]\].                                                                                                                                

  2\. Phospholipase                                                                               OH-PLA~2~, OH-acidic -1 PLA~2~ and OH-acidic-2 PLA~2~\                                                                                                                                                                                                                                                                    These PLAs recognize and hydrolyze the sn-2 acyl bonds of phospholipids releasing arachidonic acid and lysophospholipids. They have neurotoxicity, anti-coagulating activity, cardiotoxicity, myonecrotic/myotoxic activity, anti-platelet activity and edema-inducing activity \[[@B35-toxins-06-01526],[@B51-toxins-06-01526]\].
                                                                                                  PLA~2~ Hs-1 precursor                                                                                                                                                                                                                                                                                                     

                                                Phospholipase B-like 1, partial                   Unknown                                                                                                                                                                                                                                                                                                                   

  3\. Cysteine-rich secretory protein (CRiSP)                                                     *O. hannah* opharin precursor                                                                                                                                                                                                                                                                                             Binds to voltage-gated calcium channels on smooth muscle and causes high potassium-induced depolarization which weakly blocks smooth muscle contraction \[[@B52-toxins-06-01526]\].

                                                Cysteine-rich venom protein-2\                    This protein acts as an inflammatory modulator that interferes with wound-healing process of the bitten victim by regulating adhesion molecule expression on endothelial cells \[[@B53-toxins-06-01526]\] and also blocks muscle contraction evoked by potassium \[[@B54-toxins-06-01526]\].                              
                                                (Natrin-2)                                                                                                                                                                                                                                                                                                                                                                  

                                                Cysteine-rich venom protein                       Blocks contraction of smooth muscle elicited by high potassium-induced depolarization and target voltage-gated calcium channels (Cav) on smooth muscle \[[@B55-toxins-06-01526]\].                                                                                                                                        

  4\. Cobra venom factor/ complement C3                                                           *O. hannah* complement-depleting factor                                                                                                                                                                                                                                                                                   Anti-complement activity \[[@B56-toxins-06-01526]\].

  5\. Muscarinic toxin, type A                                                                    *O. hannah* muscarinic toxin-38                                                                                                                                                                                                                                                                                           This toxin binds to muscarinic acetylcholine receptor and blocks synaptic nerve transmission \[[@B57-toxins-06-01526]\].

  6\. L- amino acid oxidase                                                                       L amino acid oxidase                                                                                                                                                                                                                                                                                                      These enzymes catalyse oxidative deamination of L-amino acid to form α-keto acid, NH~4~ and H~2~O~2~. The enzymatic activity on platelet aggregation is controversial: inhibit platelet aggregation induced by ADP and the thromboxane analog U46619 *versus* induce platelet aggregation through the hydrogen peroxide formation. The H~2~O~2~ also causes edema and human cell apoptosis \[[@B58-toxins-06-01526],[@B59-toxins-06-01526],[@B60-toxins-06-01526]\]

  7\. Hypothetical protein                                                                        Hypothetical protein L345_17517\                                                                                                                                                                                                                                                                                          Unknown function
                                                                                                  Hypothetical protein L345_07470\                                                                                                                                                                                                                                                                                          
                                                                                                  Hypothetical protein L345_12124\                                                                                                                                                                                                                                                                                          
                                                                                                  Hypothetical protein L345_15308                                                                                                                                                                                                                                                                                           

  8\. Low cysteine protein                                                                        Thai cobrin                                                                                                                                                                                                                                                                                                               Thai cobrin and ohanin (protein type/family 13, Vespryn) are classified in the same low cysteine protein family \[[@B61-toxins-06-01526]\].

  9\. Phosphodiesterase-1                                                                         Phosphodiesterase-1                                                                                                                                                                                                                                                                                                       Phosphodiesterase catalyzes the hydrolysis of phosphodiester bonds of double-stranded and single-stranded DNA, rRNA, and tRNAs resulting in 5\' mononucleotide formation and subsequent release of free adenosines which are multitoxic \[[@B62-toxins-06-01526]\].

  10\. Proteases                                Metalloproteinase                                 *Protobothrops jerdonii* disintegrin                                                                                                                                                                                                                                                                                      It inhibits ADP-induced human platelet aggregation. It binds the receptor GPIIb/GPIIIa on the platelet surface resulting in hemorrhage \[[@B63-toxins-06-01526]\].

                                                Zinc metalloproteinase-disintegrin-like ohanin    Snake venom zinc metalloproteinase that has hemorrhagic activity. Inhibits ADP-, TMVA- and stejnulxin-induced platelet aggregation in a dose-dependent manner (on washed platelet, but not on platelet rich plasm). Also specifically degrades alpha-chain of fibrinogen (FGA) \[[@B64-toxins-06-01526]\]                 

                                                Zinc metalloproteinase-disintegrin-like mikarin   Snake venom zinc metalloproteinase that calcium-independently catalyzes the conversion of prothrombin (F2) to alpha-thrombin through the formation of a thrombin intermediate.\[[@B65-toxins-06-01526]\]                                                                                                                  

                                                Metalloproteinase-precursor                       unknown                                                                                                                                                                                                                                                                                                                   

  Kallikrein enzyme                             OH fibrinogenases -α and -ß                       These *O.* *hannah* venom serine proteases mediate fibrinogenolysis on both alpha and beta-chains of fibrin and amidolytic activity \[[@B66-toxins-06-01526]\].                                                                                                                                                           

  11\. Vespryn toxin                                                                              Ohanin                                                                                                                                                                                                                                                                                                                    Ohanin is a low cysteine protein. This neurotoxin causes dose-dependent hypolocomotion and hyperalgesia in mice. It may directly act on the central nervous system \[[@B61-toxins-06-01526]\].

  12\. Kunitz                                   Protease inhibitor                                *O. hannah* serine protease inhibitor; Protease inhibitor TCI\                                                                                                                                                                                                                                                            Strongly inhibit trypsin and chymotrypsin \[[@B67-toxins-06-01526]\].
                                                                                                  Venom chymotrypsin inhibitor                                                                                                                                                                                                                                                                                              

  13\. Growth factor activator                                                                    Hepatocyte growth factor activator, partial\                                                                                                                                                                                                                                                                              Unknown function
                                                                                                  Insulin-like growth factor I                                                                                                                                                                                                                                                                                              

  14\. Others                                                                                     Coagulation factor XII, partial\                                                                                                                                                                                                                                                                                          Unknown function
                                                                                                  Endonuclease domain-containing 1\                                                                                                                                                                                                                                                                                         
                                                                                                  5' nucleotidase, partial (OH)                                                                                                                                                                                                                                                                                             
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

toxins-06-01526-t006_Table A2

###### 

*O. hannah* venom components cross-reactive with horse derived *N. kaouthia* antivenin.

  Spot No(s).   Protein type/family                                                                                                     Protein name
  ------------- ----------------------------------------------------------------------------------------------------------------------- ---------------------------------------
  1 and 3       Cobra venom factor/complement C3                                                                                        OVF precursor
  2             Three finger toxin                                                                                                      Cardiotoxin-like protein
  5 and 6       Cysteine rich secretory protein (CRiSP)                                                                                 Ophanin/opharin and opharin precursor
  7 and 10      Three finger toxin which has ancestral ten cysteine arrangements; potent in birds/reptiles \[[@B61-toxins-06-01526]\]   Weak neurotoxin precursor
  8, 9 and 10   Three finger toxin                                                                                                      Long chain neurotoxins
  9 and 10      Three finger toxin                                                                                                      short chain alpha neurotoxin
  4             No match                                                                                                                No match

Wanpen Chaicumpa conceived the project, designed the experiments and served as the corresponding author. Witchuda Danpaiboon did most experiments; Onrapak Reamtong performed LC-MS/MS and protein identification; Yuwaporn Sakolvaree performed 2DE and 2DE immunoblotting; Watee Seesuay performed protein homology modeling and molecular docking; Witchuda Danpaiboon and Fonthip Dong-din-on performed neutralization tests; Wanpen Chaicumpa, Nitat Sookrung, Jeeraphong Thanongsaksrikul, Kanyarat Thueng-in and Potjanee Srimanote supervised Witchuda Danpaiboon; Wanpen Chaicumpa, Witchuda Danpaiboon, Onrapak Reamtong and Watee Seesuay prepared the manuscript.

The authors declare no conflict of interest.
